MicroBioGen
Geoffrey Bell is currently the CEO of Microbiogen and has been leading the company since 2006. Prior to this role, Geoffrey worked at BNP Paribas as the Head of Asia Pacific Research and at Prudential Bache Securities as a Mining analyst. Geoffrey has a M.App.Fin degree from Macquarie University, a BEc degree in Economics and Finance from Macquarie University, and a BSc degree in Geology and Geophysics from the University of Sydney. Their experience includes attending international conferences, negotiating licensing deals, designing financial models, and managing board meetings.
This person is not in any teams
MicroBioGen
MicroBioGen is the world leader in the development of superior yeast biocatalysts for a wide range of industrial applications. The yeast biocatalysts we specialise in underpin products worth more than US$1 trillion per year. Our unique platform technology can also be applied to human food, animal feed, enzymes, protein vectors, probiotics, biochemicals and even space exploration. Together with our current and future valued partners, customers and shareholders, we are excited to be building a more sustainable future through our unique, proprietary, long term and high-tech development programs. Our highly advanced Saccharomyces cerevisiae yeast products – used for the Novozymes Innova series – are quickly becoming the new industry standards for the production of a range of 1st generation biofuels. We are also in the final stages of developing a yeast product in collaboration with a major global corporate for 2nd generation biofuels, with ARENA (The Australian Renewable Energy Agency) supporting us in a $8M optimisation programme.